GGrantIndex
← Search

MISOPROSTOL INHIBITION OF SYSTEMIC MAST CELL ACTIVATION

$0M01FY2000RRNIH

Vanderbilt University, Nashville TN

Investigators

Linked publications & trials

Abstract

This study is to assess the efficacy of treatment with misoprostil to inhibit episodes of systemic mastocyte activation in patients with idiopathic anaphylactoid attacks, aspirin-induced anaphylactoid attacks, and systemic mastocytosis. This has been a long-term study on which we track the patients. New treatment regimens are being will be developed for these patients.

View original record on NIH RePORTER →